Circumferential Lesions – Friday Pop Quiz 9/1/2023
A patient presents with chronic swelling of the lower extremities and circumferential lesions on both lower legs of several years duration. The patient's legs are now as shown in the image. Which of the following is the most likely diagnosis?
A. Lipodermatosclerosis
B. Elephantiasis nostras verrucosa
C. Deep fungal infection
D. Podoconiosis
E. Pigmented purpuric dermatosis
To f …
A patient presents with chronic swelling of the lower extremities and circumferential lesions on both lower legs of several years duration. The patient's legs are now as shown in the image. Which of the following is the most likely diagnosis?
A. Lipodermatosclerosis
B. Elephantiasis nostras verrucosa
C. Deep fungal infection
D. Podoconiosis
E. Pigmented purpuric dermatosis
To f … Continue reading "Circumferential Lesions – Friday Pop Quiz 9/1/2023"
JDD authors Dimitra Xenopoulou MS, Christopher Pochat MS, and Evelyn Greco DO present the findings of a successful treatment for verrucous psoriasis.
CASE
A 64-year-old female presented to the outpatient clinic for the evaluation of flaking and itchy lesions on her bilateral hands and feet that were present for several months and caused difficulty with activities of daily living. Inconsist … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Andrew Alexis, co-chair of Skin of Color Update, and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. Dr. Alexis shares his take on how to address issues of mistrust that may impede clinical trial recruitment in diverse patient populations. Watch as he details why i … 
Neurotoxins are the mainstay for multiple aesthetic and medical treatments. They are safe and effective treatment for rhytides, but are also temporary, requiring repeat injections about every 3-4 months.1,2 Now, a recently approved formulation of neurotoxin is fulfilling some patient’s desire for a longer lasting effect. Injection of daxibotulinumtoxinA is FDA-approved for treatment of moderate … 
This is limited to the patient's skin and hair. What is the mutation in this condition?
A. PAX3
B. C-KIT
C. MITF
D. Endothelin-3
E. NEMO
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
…